EXTENDED PHENYTOIN SODIUM

EXTENDED PHENYTOIN SODIUM was reported 16679 times

EXTENDED PHENYTOIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTICONVULSANT TOXICITY 19 0.3800
1 ANTICONVULSANT DRUG LEVEL ABNORMAL 61 0.3466
2 ANTICONVULSANT DRUG LEVEL DECREASED 369 0.2611
3 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 162 0.2151
4 ANTICONVULSANT DRUG LEVEL INCREASED 315 0.1949
5 CEREBELLAR ATROPHY 124 0.1407
6 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 72 0.1108
7 DRUG LEVEL FLUCTUATING 69 0.0777
8 DRUG LEVEL CHANGED 47 0.0746
9 EPILEPTIC AURA 16 0.0620
10 GINGIVAL HYPERPLASIA 33 0.0551
11 AURA 88 0.0471
12 COMPLEX PARTIAL SEIZURES 48 0.0432
13 VAGAL NERVE STIMULATOR IMPLANTATION 12 0.0392
14 CONVULSION 2169 0.0379
15 ENCEPHALOMALACIA 21 0.0373
16 SIMPLE PARTIAL SEIZURES 29 0.0359
17 GRAND MAL CONVULSION 330 0.0357
18 FOCAL DYSCOGNITIVE SEIZURES 32 0.0281
19 GLIOBLASTOMA MULTIFORME 22 0.0261
20 TEMPORAL LOBE EPILEPSY 11 0.0252
21 DRUG LEVEL DECREASED 251 0.0246
22 PETIT MAL EPILEPSY 108 0.0211
23 STEVENS-JOHNSON SYNDROME 468 0.0210
24 TRANSVERSE SINUS THROMBOSIS 11 0.0209
25 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 84 0.0202
26 CEREBELLAR ATAXIA 19 0.0198
27 PARTIAL SEIZURES 100 0.0191
28 THROAT LESION 12 0.0175
29 BRAIN OPERATION 38 0.0166
30 POSTICTAL STATE 17 0.0164
31 INTRACRANIAL VENOUS SINUS THROMBOSIS 17 0.0159
32 GINGIVAL DISORDER 61 0.0159
33 GINGIVAL HYPERTROPHY 24 0.0158
34 DRUG LEVEL BELOW THERAPEUTIC 86 0.0156
35 GENERALISED TONIC-CLONIC SEIZURE 257 0.0155
36 APALLIC SYNDROME 11 0.0152
37 SEIZURE CLUSTER 12 0.0145
38 THERAPEUTIC AGENT TOXICITY 48 0.0144
39 ATONIC SEIZURES 12 0.0140
40 ATAXIA 161 0.0136
41 NYSTAGMUS 70 0.0132
42 SEIZURE 1439 0.0124
43 DEMENTIA ALZHEIMER'S TYPE 19 0.0114
44 DRUG TOXICITY 154 0.0113
45 CEREBRAL ATROPHY 45 0.0113
46 PHARMACEUTICAL PRODUCT COMPLAINT 292 0.0112
47 TONGUE BITING 23 0.0111
48 COORDINATION ABNORMAL 154 0.0110
49 ORAL INTAKE REDUCED 25 0.0103
50 DRUG LEVEL INCREASED 171 0.0103
51 STATUS EPILEPTICUS 116 0.0103
52 NEPHROGENIC SYSTEMIC FIBROSIS 31 0.0102
53 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0098
54 STARING 23 0.0095
55 GINGIVAL SWELLING 42 0.0095
56 DRUG WITHDRAWAL CONVULSIONS 16 0.0090
57 FEELING DRUNK 66 0.0089
58 ELECTROENCEPHALOGRAM ABNORMAL 28 0.0089
59 BRAIN INJURY 86 0.0086
60 DRUG LEVEL ABOVE THERAPEUTIC 39 0.0085
61 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 12 0.0083
62 NEUROPATHY 14 0.0082
63 TOXIC EPIDERMAL NECROLYSIS 125 0.0082
64 GLIOBLASTOMA 14 0.0082
65 SKIN INDURATION 17 0.0082
66 GINGIVAL RECESSION 15 0.0078
67 COAGULATION TIME PROLONGED 12 0.0077
68 FACIAL BONES FRACTURE 27 0.0075
69 SKULL FRACTURE 12 0.0074
70 CHANGE OF BOWEL HABIT 15 0.0073
71 MYOCLONIC EPILEPSY 11 0.0072
72 INHIBITORY DRUG INTERACTION 11 0.0069
73 BRAIN NEOPLASM 63 0.0069
74 CEREBELLAR SYNDROME 15 0.0068
75 BODY HEIGHT DECREASED 73 0.0068
76 DIFFICULTY IN WALKING 23 0.0067
77 BONE MARROW DISORDER 20 0.0066
78 READING DISORDER 15 0.0066
79 IMPAIRED DRIVING ABILITY 69 0.0061
80 EPILEPSY 177 0.0058
81 CAROTID ARTERY STENOSIS 20 0.0057
82 INCOHERENT 37 0.0057
83 MENTAL STATUS CHANGES 158 0.0057
84 DYSARTHRIA 213 0.0057
85 JAW FRACTURE 12 0.0056
86 HEMIPARESIS 92 0.0054
87 TONGUE ULCERATION 18 0.0053
88 HEPATOCELLULAR DAMAGE 12 0.0053
89 OESOPHAGEAL DISORDER 20 0.0052
90 NEUROLOGICAL DECOMPENSATION 12 0.0052
91 MULTIPLE-DRUG RESISTANCE 16 0.0052
92 INGROWING NAIL 12 0.0051
93 DRUG SCREEN FALSE POSITIVE 14 0.0051
94 BLOOD PRESSURE DIASTOLIC INCREASED 23 0.0050
95 INTERNATIONAL NORMALISED RATIO DECREASED 20 0.0049
96 BALANCE DISORDER 422 0.0049
97 VITAMIN B12 DECREASED 14 0.0049
98 INFREQUENT BOWEL MOVEMENTS 12 0.0048
99 APHAGIA 23 0.0048
100 EXCORIATION 12 0.0047
101 COMMUNICATION DISORDER 18 0.0047
102 CLAVICLE FRACTURE 18 0.0047
103 HOMICIDAL IDEATION 19 0.0047
104 AMNESIA 303 0.0047
105 DIABETIC COMA 13 0.0046
106 CERVICAL VERTEBRAL FRACTURE 16 0.0046
107 SKIN HYPERTROPHY 13 0.0046
108 PERSONALITY DISORDER 12 0.0046
109 SPINAL OSTEOARTHRITIS 40 0.0045
110 PHARYNGOLARYNGEAL PAIN 24 0.0045
111 ANGIONEUROTIC OEDEMA 12 0.0045
112 HEAD INJURY 142 0.0045
113 STOMACH DISCOMFORT 23 0.0044
114 GINGIVITIS 24 0.0044
115 ACTIVITIES OF DAILY LIVING IMPAIRED 88 0.0044
116 VISUAL FIELD DEFECT 32 0.0044
117 ANEURYSM 22 0.0044
118 CLUMSINESS 12 0.0044
119 BRAIN OEDEMA 55 0.0043
120 LOOSE TOOTH 14 0.0043
121 HEARING IMPAIRED 26 0.0043
122 DIABETIC NEUROPATHY 21 0.0042
123 APHASIA 126 0.0042
124 APPARENT DEATH 15 0.0042
125 BLOOD POTASSIUM ABNORMAL 11 0.0041
126 AMMONIA INCREASED 21 0.0041
127 DYSPHEMIA 18 0.0041
128 THERMAL BURN 29 0.0041
129 APLASIA PURE RED CELL 14 0.0041
130 ABASIA 100 0.0040
131 NERVE INJURY 45 0.0040
132 RIB FRACTURE 83 0.0040
133 BLOOD ALBUMIN DECREASED 32 0.0040
134 BRAIN HERNIATION 12 0.0040
135 THYROID NEOPLASM 11 0.0040
136 ERYTHEMA MULTIFORME 37 0.0040
137 THROMBOPHLEBITIS SUPERFICIAL 12 0.0040
138 EYE MOVEMENT DISORDER 27 0.0039
139 LACERATION 37 0.0039
140 ATELECTASIS 38 0.0039
141 SPEECH DISORDER 206 0.0039
142 ECONOMIC PROBLEM 58 0.0038
143 HUMERUS FRACTURE 18 0.0037
144 ENURESIS 15 0.0037
145 POSTURE ABNORMAL 12 0.0037
146 PERIPHERAL VASCULAR DISORDER 19 0.0037
147 INTERVERTEBRAL DISC DEGENERATION 34 0.0037
148 TYPE 1 DIABETES MELLITUS 22 0.0036
149 RASH MACULO-PAPULAR 81 0.0036
150 SUBDURAL HAEMATOMA 52 0.0036
151 CONCUSSION 28 0.0036
152 SKIN TIGHTNESS 17 0.0036
153 HYPERLIPIDAEMIA 43 0.0036
154 MASTICATION DISORDER 11 0.0036
155 EMPHYSEMA 36 0.0036
156 NEOPLASM RECURRENCE 12 0.0035
157 BLADDER DISORDER 35 0.0035
158 ANGER 119 0.0035
159 WRIST FRACTURE 42 0.0035
160 ANOREXIA 45 0.0035
161 INTRACRANIAL ANEURYSM 14 0.0035
162 LETHARGY 199 0.0035
163 MALABSORPTION 18 0.0034
164 OSTEOPOROSIS 141 0.0034
165 BREAST MASS 23 0.0034
166 STUPOR 11 0.0034
167 DERMATITIS EXFOLIATIVE 17 0.0034
168 HAND FRACTURE 24 0.0034
169 PROTHROMBIN TIME PROLONGED 20 0.0033
170 FAECAL INCONTINENCE 16 0.0033
171 ROAD TRAFFIC ACCIDENT 139 0.0033
172 PROSTATOMEGALY 13 0.0033
173 LYME DISEASE 11 0.0033
174 GINGIVAL BLEEDING 45 0.0033
175 LUNG NEOPLASM 14 0.0033
176 APLASTIC ANAEMIA 17 0.0033
177 CLOSTRIDIAL INFECTION 11 0.0032
178 PARANOIA 56 0.0032
179 HEMIPLEGIA 27 0.0032
180 TRIGEMINAL NEURALGIA 13 0.0032
181 OSTEOPENIA 49 0.0032
182 BLOOD CALCIUM DECREASED 36 0.0032
183 PROTEIN TOTAL DECREASED 12 0.0032
184 FEAR 85 0.0032
185 SCAR 54 0.0032
186 WHEELCHAIR USER 14 0.0031
187 TOOTH LOSS 65 0.0031
188 BIPOLAR DISORDER 34 0.0031
189 LOGORRHOEA 11 0.0031
190 RENAL FAILURE CHRONIC 24 0.0031
191 CEREBRAL DISORDER 23 0.0031
192 JAW DISORDER 17 0.0031
193 METABOLIC DISORDER 18 0.0031
194 POOR QUALITY DRUG ADMINISTERED 20 0.0031
195 FAILURE TO THRIVE 16 0.0031
196 DECUBITUS ULCER 25 0.0031
197 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
198 DROOLING 21 0.0030
199 DYSGRAPHIA 20 0.0030
200 INCONTINENCE 32 0.0030
201 BONE DISORDER 55 0.0030
202 UPPER LIMB FRACTURE 60 0.0030
203 SECOND PRIMARY MALIGNANCY 25 0.0030
204 DRUG INTERACTION 475 0.0030
205 CANDIDIASIS 12 0.0030
206 NERVOUS SYSTEM DISORDER 93 0.0030
207 TONGUE DISCOLOURATION 13 0.0030
208 BODY TEMPERATURE DECREASED 29 0.0029
209 URINARY INCONTINENCE 87 0.0029
210 SCOLIOSIS 18 0.0029
211 TOOTH FRACTURE 32 0.0029
212 CONFUSIONAL STATE 469 0.0029
213 COMA 138 0.0029
214 RENAL CYST 23 0.0029
215 BEDRIDDEN 38 0.0029
216 MAJOR DEPRESSION 21 0.0029
217 BLOOD SODIUM DECREASED 54 0.0029
218 SEDATION 75 0.0029
219 PELVIC FRACTURE 22 0.0028
220 HYPERNATRAEMIA 14 0.0028
221 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
222 TREMOR 464 0.0028
223 FOOT FRACTURE 53 0.0028
224 TENSION HEADACHE 12 0.0028
225 VISUAL DISTURBANCE 16 0.0028
226 MUSCLE TWITCHING 64 0.0028
227 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
228 FALL 919 0.0028
229 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
230 BACK INJURY 30 0.0028
231 ABNORMAL BEHAVIOUR 109 0.0027
232 ENCEPHALITIS 19 0.0027
233 TOOTH DISORDER 61 0.0027
234 WALKING AID USER 18 0.0027
235 PRODUCT FORMULATION ISSUE 18 0.0027
236 MUSCLE TIGHTNESS 44 0.0027
237 DENTAL CARIES 30 0.0027
238 HIATUS HERNIA 35 0.0027
239 NEOPLASM 31 0.0027
240 DIPLOPIA 70 0.0027
241 PERIPHERAL ISCHAEMIA 11 0.0027
242 HAEMORRHAGIC STROKE 21 0.0027
243 POST-TRAUMATIC STRESS DISORDER 18 0.0027
244 BRAIN NEOPLASM MALIGNANT 12 0.0027
245 DRUG DISPENSING ERROR 41 0.0027
246 DYSKINESIA 109 0.0027
247 COGNITIVE DISORDER 125 0.0027
248 BLOOD MAGNESIUM DECREASED 23 0.0027
249 HYPERSOMNIA 76 0.0026
250 COAGULOPATHY 44 0.0026
251 URINE OUTPUT DECREASED 23 0.0026
252 MEMORY IMPAIRMENT 361 0.0026
253 ANHEDONIA 69 0.0026
254 BRUXISM 14 0.0026
255 AORTIC VALVE INCOMPETENCE 11 0.0026
256 MOOD SWINGS 82 0.0026
257 BLOOD COUNT ABNORMAL 39 0.0026
258 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
259 JOINT DISLOCATION 27 0.0026
260 TRANSIENT ISCHAEMIC ATTACK 86 0.0025
261 MONOPLEGIA 11 0.0025
262 GINGIVAL PAIN 20 0.0025
263 INTRACRANIAL PRESSURE INCREASED 14 0.0025
264 BLOOD CHOLESTEROL INCREASED 117 0.0025
265 AGGRESSION 125 0.0025
266 BLOOD DISORDER 20 0.0025
267 OBSESSIVE-COMPULSIVE DISORDER 20 0.0025
268 PNEUMONIA ASPIRATION 62 0.0025
269 PRESCRIBED OVERDOSE 48 0.0025
270 THINKING ABNORMAL 46 0.0025
271 SLEEP APNOEA SYNDROME 47 0.0025
272 GAIT DISTURBANCE 471 0.0025
273 SUBARACHNOID HAEMORRHAGE 25 0.0025
274 MOTOR DYSFUNCTION 25 0.0025
275 REFUSAL OF TREATMENT BY PATIENT 16 0.0024
276 NERVOUSNESS 128 0.0024
277 BRADYPHRENIA 16 0.0024
278 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
279 SPINAL FRACTURE 49 0.0024
280 APNOEA 19 0.0024
281 DRUG EXPOSURE DURING PREGNANCY 83 0.0024
282 ACCIDENT 29 0.0024
283 SOMNOLENCE 488 0.0024
284 BLOOD ALKALINE PHOSPHATASE INCREASED 60 0.0024
285 STRESS FRACTURE 13 0.0024
286 PROTEIN URINE PRESENT 12 0.0024
287 DRUG SCREEN POSITIVE 19 0.0024
288 ENCEPHALOPATHY 59 0.0024
289 BUNDLE BRANCH BLOCK RIGHT 11 0.0024
290 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 125 0.0024
291 HYPOVOLAEMIA 14 0.0024
292 JOINT INJURY 51 0.0024
293 BLOOD CHOLESTEROL ABNORMAL 11 0.0024
294 VITAMIN D DEFICIENCY 23 0.0024
295 TOOTH ABSCESS 24 0.0024
296 BLOOD TEST ABNORMAL 33 0.0023
297 DISORIENTATION 93 0.0023
298 LOWER LIMB FRACTURE 45 0.0023
299 PRODUCT COLOUR ISSUE 12 0.0023
300 SPINAL COLUMN STENOSIS 11 0.0023
301 LIGAMENT SPRAIN 23 0.0023
302 LOSS OF CONSCIOUSNESS 298 0.0023
303 HAEMATOCRIT DECREASED 46 0.0023
304 DECREASED ACTIVITY 25 0.0023
305 MULTI-ORGAN FAILURE 40 0.0023
306 LYMPHOEDEMA 16 0.0023
307 HIP FRACTURE 74 0.0023
308 SPINAL COMPRESSION FRACTURE 19 0.0023
309 DEEP VEIN THROMBOSIS 149 0.0023
310 INTERVERTEBRAL DISC PROTRUSION 50 0.0023
311 MENTAL IMPAIRMENT 55 0.0023
312 TRICUSPID VALVE INCOMPETENCE 18 0.0023
313 ANKLE FRACTURE 35 0.0023
314 BODY TEMPERATURE INCREASED 46 0.0023
315 METASTASES TO CENTRAL NERVOUS SYSTEM 29 0.0022
316 PRE-EXISTING CONDITION IMPROVED 14 0.0022
317 OVERWEIGHT 12 0.0022
318 CEREBROVASCULAR ACCIDENT 378 0.0022
319 TYPE 2 DIABETES MELLITUS 75 0.0022
320 UNRESPONSIVE TO STIMULI 57 0.0022
321 HYDROCEPHALUS 12 0.0022
322 SCREAMING 14 0.0022
323 CARDIAC MURMUR 19 0.0022
324 CARDIOMEGALY 27 0.0022
325 TREATMENT NONCOMPLIANCE 120 0.0022
326 PRODUCT SUBSTITUTION ISSUE 126 0.0022
327 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
328 DYSPHAGIA 205 0.0022
329 DYSSTASIA 62 0.0021
330 INJURY 149 0.0021
331 DRUG ABUSER 13 0.0021
332 VITAMIN D DECREASED 18 0.0021
333 CHOLECYSTECTOMY 24 0.0021
334 PARALYSIS 30 0.0021
335 DIABETES MELLITUS 159 0.0021
336 MUSCULAR WEAKNESS 236 0.0021
337 TONGUE DISORDER 15 0.0021
338 DERMATITIS BULLOUS 15 0.0021
339 HICCUPS 17 0.0021
340 RENAL FAILURE ACUTE 87 0.0020
341 EMOTIONAL DISORDER 63 0.0020
342 CEREBRAL HAEMORRHAGE 73 0.0020
343 ARTERIAL OCCLUSIVE DISEASE 16 0.0020
344 HEPATOMEGALY 20 0.0020
345 POST PROCEDURAL COMPLICATION 39 0.0020
346 LIVER FUNCTION TEST ABNORMAL 59 0.0020
347 VENTRICULAR EXTRASYSTOLES 21 0.0020
348 OBESITY 32 0.0020
349 EXTRASYSTOLES 14 0.0020
350 PAROSMIA 15 0.0020
351 BLINDNESS UNILATERAL 28 0.0020
352 MUSCLE STRAIN 17 0.0020
353 IMPAIRED WORK ABILITY 42 0.0020
354 DEPRESSION 447 0.0020
355 INTERNATIONAL NORMALISED RATIO INCREASED 56 0.0020
356 SPLENOMEGALY 23 0.0020
357 ANGIOPATHY 11 0.0020
358 HALLUCINATION, AUDITORY 31 0.0019
359 MENINGITIS 13 0.0019
360 NEUROPATHY PERIPHERAL 185 0.0019
361 MITRAL VALVE INCOMPETENCE 22 0.0019
362 GRANULOCYTOPENIA 11 0.0019
363 NEUROLOGICAL SYMPTOM 11 0.0019
364 CEREBRAL INFARCTION 47 0.0019
365 DIABETES MELLITUS INADEQUATE CONTROL 34 0.0019
366 ASPIRATION 21 0.0019
367 MULTIPLE INJURIES 12 0.0019
368 PHOTOPSIA 12 0.0019
369 BLOOD POTASSIUM DECREASED 57 0.0019
370 HAEMORRHAGE INTRACRANIAL 28 0.0019
371 ORAL DISCOMFORT 26 0.0019
372 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
373 FEELING ABNORMAL 445 0.0019
374 CARDIAC FLUTTER 12 0.0019
375 AGITATION 136 0.0018
376 ODYNOPHAGIA 11 0.0018
377 WEIGHT DECREASED 514 0.0018
378 RENAL TUBULAR NECROSIS 18 0.0018
379 MOOD ALTERED 50 0.0018
380 TOXICITY TO VARIOUS AGENTS 309 0.0018
381 SINUS TACHYCARDIA 26 0.0018
382 PERSONALITY CHANGE 17 0.0018
383 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
384 LUNG INFILTRATION 16 0.0018
385 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
386 LYMPHADENOPATHY 64 0.0018
387 DRUG ERUPTION 32 0.0018
388 EOSINOPHIL COUNT INCREASED 15 0.0018
389 BLOOD UREA INCREASED 30 0.0018
390 HAEMODIALYSIS 15 0.0018
391 HYPOTHYROIDISM 57 0.0018
392 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
393 UNEVALUABLE EVENT 135 0.0018
394 MYOSITIS 16 0.0018
395 HYPOAESTHESIA 266 0.0018
396 NEURALGIA 43 0.0018
397 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 12 0.0018
398 CYSTITIS 56 0.0018
399 DEMENTIA 49 0.0018
400 ECCHYMOSIS 12 0.0017
401 CORONARY ARTERY DISEASE 53 0.0017
402 CORONARY ARTERY OCCLUSION 24 0.0017
403 GASTRITIS 46 0.0017
404 SKIN LACERATION 19 0.0017
405 DIZZINESS 856 0.0017
406 APPENDICITIS 16 0.0017
407 TOOTHACHE 31 0.0017
408 SUICIDAL IDEATION 156 0.0017
409 SPINAL DISORDER 16 0.0017
410 DISTURBANCE IN ATTENTION 91 0.0017
411 HYPOTHERMIA 17 0.0017
412 FEELING JITTERY 32 0.0017
413 SLUGGISHNESS 17 0.0017
414 SWOLLEN TONGUE 52 0.0017
415 RASH GENERALISED 43 0.0017
416 PSYCHOTIC DISORDER 49 0.0017
417 HEPATIC FAILURE 50 0.0017
418 TORSADE DE POINTES 13 0.0017
419 OSTEOMYELITIS 30 0.0017
420 LIMB INJURY 45 0.0017
421 AFFECTIVE DISORDER 13 0.0017
422 OEDEMA PERIPHERAL 201 0.0016
423 PANIC ATTACK 60 0.0016
424 EYE DISORDER 54 0.0016
425 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
426 JOINT RANGE OF MOTION DECREASED 22 0.0016
427 TINNITUS 75 0.0016
428 BLINDNESS TRANSIENT 12 0.0016
429 INTENTIONAL DRUG MISUSE 34 0.0016
430 VISUAL ACUITY REDUCED 54 0.0016
431 DRUG EFFECT DECREASED 87 0.0016
432 SENSORY LOSS 13 0.0016
433 IRRITABILITY 97 0.0016
434 BURNING SENSATION 113 0.0016
435 PRODUCT DISPENSING ERROR 35 0.0016
436 HEPATITIS 41 0.0016
437 ARTERIOSCLEROSIS 15 0.0016
438 DEPRESSED LEVEL OF CONSCIOUSNESS 63 0.0016
439 MACULAR DEGENERATION 19 0.0016
440 PANCREATITIS 84 0.0016
441 HAEMORRHOIDS 31 0.0016
442 HEREDITARY ANGIOEDEMA 17 0.0016
443 NEOPLASM PROGRESSION 55 0.0016
444 ESCHERICHIA INFECTION 13 0.0016
445 AORTIC ANEURYSM 12 0.0016
446 CRYING 57 0.0016
447 PROCEDURAL COMPLICATION 12 0.0016
448 PULMONARY THROMBOSIS 17 0.0016
449 ROTATOR CUFF SYNDROME 20 0.0016
450 THYROID DISORDER 24 0.0016
451 ATRIOVENTRICULAR BLOCK 12 0.0016
452 EATING DISORDER 33 0.0015
453 DIVERTICULUM 11 0.0015
454 LOCAL SWELLING 27 0.0015
455 BLINDNESS 63 0.0015
456 PHOTOPHOBIA 29 0.0015
457 BLOOD POTASSIUM INCREASED 25 0.0015
458 RESPIRATORY FAILURE 112 0.0015
459 TENDERNESS 16 0.0015
460 FOOT DEFORMITY 17 0.0015
461 SKIN LESION 42 0.0015
462 VISION BLURRED 210 0.0015
463 CELLULITIS 77 0.0015
464 TOOTH EXTRACTION 19 0.0015
465 PRURITUS GENERALISED 33 0.0015
466 ASTHENIA 573 0.0015
467 RESPIRATORY ARREST 42 0.0015
468 MALNUTRITION 17 0.0015
469 PULMONARY CONGESTION 20 0.0015
470 CONTUSION 146 0.0015
471 PHOTOSENSITIVITY REACTION 25 0.0015
472 HYSTERECTOMY 13 0.0015
473 ORAL DISORDER 11 0.0015
474 MOUTH HAEMORRHAGE 11 0.0015
475 HAEMATEMESIS 38 0.0015
476 SEPTIC SHOCK 65 0.0015
477 FLANK PAIN 14 0.0015
478 POOR QUALITY SLEEP 32 0.0015
479 FRUSTRATION TOLERANCE DECREASED 12 0.0015
480 END STAGE RENAL DISEASE 27 0.0015
481 NO THERAPEUTIC RESPONSE 18 0.0015
482 MEDICATION ERROR 82 0.0015
483 MENTAL DISORDER 64 0.0015
484 RESPIRATORY RATE INCREASED 13 0.0015
485 CYANOSIS 23 0.0015
486 OSTEOARTHRITIS 62 0.0015
487 DRUG PRESCRIBING ERROR 28 0.0015
488 DEHYDRATION 194 0.0015
489 DEAFNESS 38 0.0015
490 NECK PAIN 81 0.0014
491 HERNIA 28 0.0014
492 CARDIAC FAILURE CONGESTIVE 116 0.0014
493 GASTROOESOPHAGEAL REFLUX DISEASE 116 0.0014
494 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
495 INSOMNIA 382 0.0014
496 MOUTH ULCERATION 30 0.0014
497 LIMB DISCOMFORT 44 0.0014
498 SINUS DISORDER 28 0.0014
499 BLOOD THYROID STIMULATING HORMONE INCREASED 13 0.0014
500 WHITE BLOOD CELL COUNT INCREASED 54 0.0014
501 THROMBOSIS 113 0.0014
502 HYPERTENSION 297 0.0014
503 MOVEMENT DISORDER 45 0.0014
504 WEIGHT INCREASED 313 0.0014
505 RECTAL HAEMORRHAGE 60 0.0014
506 HALLUCINATION 105 0.0014
507 RENAL FAILURE 185 0.0014
508 BLOOD PRESSURE INCREASED 213 0.0014
509 CENTRAL NERVOUS SYSTEM LESION 19 0.0014
510 RESTLESS LEGS SYNDROME 25 0.0014
511 HALLUCINATION, VISUAL 29 0.0014
512 OESOPHAGITIS 15 0.0014
513 BONE DENSITY DECREASED 43 0.0014
514 HEART RATE IRREGULAR 31 0.0014
515 BLISTER 77 0.0014
516 HYPOACUSIS 59 0.0014
517 POLLAKIURIA 57 0.0014
518 SEXUAL DYSFUNCTION 16 0.0014
519 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
520 ANXIETY 388 0.0014
521 HYPOXIA 48 0.0014
522 MASS 19 0.0014
523 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
524 POISONING 17 0.0014
525 AFFECT LABILITY 13 0.0013
526 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
527 WRONG TECHNIQUE IN DRUG USAGE PROCESS 49 0.0013
528 RENAL INJURY 40 0.0013
529 SLEEP DISORDER 95 0.0013
530 FACIAL PAIN 12 0.0013
531 COLON CANCER 20 0.0013
532 FULL BLOOD COUNT DECREASED 27 0.0013
533 RASH ERYTHEMATOUS 64 0.0013
534 WEIGHT FLUCTUATION 14 0.0013
535 ALANINE AMINOTRANSFERASE INCREASED 82 0.0013
536 HEADACHE 836 0.0013
537 PARKINSONISM 13 0.0013
538 RED BLOOD CELL COUNT DECREASED 38 0.0013
539 CHROMATURIA 30 0.0013
540 CHEST PAIN 246 0.0013
541 CATARACT 79 0.0013
542 KIDNEY INFECTION 26 0.0013
543 ERECTILE DYSFUNCTION 34 0.0013
544 FRACTURE 25 0.0013
545 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
546 ILL-DEFINED DISORDER 80 0.0013
547 VISUAL IMPAIRMENT 163 0.0013
548 EAR INFECTION 35 0.0013
549 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 63 0.0013
550 CHOLELITHIASIS 43 0.0013
551 SENSORY DISTURBANCE 21 0.0013
552 STAPHYLOCOCCAL INFECTION 43 0.0013
553 UROSEPSIS 12 0.0013
554 PHARYNGEAL OEDEMA 20 0.0013
555 HEAD DISCOMFORT 23 0.0013
556 GLAUCOMA 25 0.0013
557 VERTIGO 79 0.0013
558 GLOSSODYNIA 29 0.0013
559 CONDITION AGGRAVATED 393 0.0013
560 ORAL CANDIDIASIS 17 0.0013
561 SKIN DISCOLOURATION 59 0.0013
562 ABORTION INDUCED 12 0.0013
563 RASH 555 0.0013
564 LEUKOCYTOSIS 23 0.0013
565 BRONCHITIS 94 0.0013
566 RESPIRATORY DISTRESS 35 0.0013
567 ABNORMAL DREAMS 35 0.0013
568 LUNG NEOPLASM MALIGNANT 52 0.0013
569 BONE LOSS 19 0.0013
570 ASPARTATE AMINOTRANSFERASE INCREASED 67 0.0013
571 HYPONATRAEMIA 71 0.0013
572 CHOLECYSTITIS 15 0.0013
573 RASH MACULAR 44 0.0013
574 PULMONARY EMBOLISM 119 0.0013
575 DYSURIA 46 0.0012
576 PREGNANCY 25 0.0012
577 FACE OEDEMA 21 0.0012
578 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
579 HYPERTHYROIDISM 18 0.0012
580 HYPERCHOLESTEROLAEMIA 12 0.0012
581 EYE INFECTION 14 0.0012
582 LEUKOPENIA 62 0.0012
583 DIZZINESS POSTURAL 12 0.0012
584 EAR PAIN 24 0.0012
585 DEVICE RELATED INFECTION 19 0.0012
586 SCRATCH 13 0.0012
587 BONE MARROW FAILURE 25 0.0012
588 BACK DISORDER 20 0.0012
589 SKIN DISORDER 41 0.0012
590 MOBILITY DECREASED 88 0.0012
591 ANAL INCONTINENCE 11 0.0012
592 DRUG INTOLERANCE 118 0.0012
593 DEVELOPMENTAL DELAY 11 0.0012
594 BREAST PAIN 13 0.0012
595 CARDIAC DISORDER 114 0.0012
596 MULTIPLE FRACTURES 20 0.0012
597 MIGRAINE 116 0.0012
598 HYPERCALCAEMIA 15 0.0012
599 URINARY TRACT INFECTION 207 0.0012
600 INTENTIONAL PRODUCT MISUSE 106 0.0012
601 PHARYNGITIS 15 0.0012
602 CYST 15 0.0012
603 HYPERGLYCAEMIA 44 0.0012
604 ORAL PAIN 27 0.0012
605 SEASONAL ALLERGY 17 0.0012
606 FAECES DISCOLOURED 26 0.0012
607 DYSPHONIA 70 0.0012
608 ACUTE RESPIRATORY FAILURE 23 0.0012
609 INCREASED TENDENCY TO BRUISE 11 0.0012
610 ARTHRITIS 94 0.0012
611 FEMUR FRACTURE 37 0.0012
612 QUALITY OF LIFE DECREASED 16 0.0012
613 IRON DEFICIENCY ANAEMIA 11 0.0012
614 MUSCLE ATROPHY 15 0.0012
615 BLOOD IRON DECREASED 14 0.0012
616 BLOOD PRESSURE SYSTOLIC INCREASED 23 0.0012
617 DEFORMITY 11 0.0012
618 ISCHAEMIC STROKE 21 0.0012
619 PALLOR 32 0.0012
620 DRUG ADMINISTRATION ERROR 36 0.0012
621 NEUTROPHIL COUNT INCREASED 12 0.0012
622 HYPOKALAEMIA 54 0.0012
623 DISEASE PROGRESSION 138 0.0012
624 GASTRIC DISORDER 40 0.0012
625 RASH PRURITIC 63 0.0012
626 PNEUMONIA 376 0.0012
627 LOCALISED INFECTION 28 0.0012
628 MANIA 19 0.0012
629 MENINGIOMA 18 0.0012
630 DELIRIUM 40 0.0012
631 FIBROMYALGIA 28 0.0012
632 PETECHIAE 12 0.0011
633 FEELING COLD 32 0.0011
634 MYOCARDIAL INFARCTION 200 0.0011
635 VOMITING 539 0.0011
636 APHONIA 16 0.0011
637 LIP SWELLING 38 0.0011
638 POOR QUALITY PRODUCT ADMINISTERED 12 0.0011
639 MICTURITION URGENCY 13 0.0011
640 HYPOPHAGIA 29 0.0011
641 PRODUCT PRESCRIBING ERROR 27 0.0011
642 RENAL PAIN 12 0.0011
643 ULCER 18 0.0011
644 PARAESTHESIA 178 0.0011
645 HEART RATE INCREASED 112 0.0011
646 PAIN IN JAW 32 0.0011
647 CONSTIPATION 246 0.0011
648 HEPATIC STEATOSIS 21 0.0011
649 CANDIDA INFECTION 19 0.0011
650 SKIN ULCER 29 0.0011
651 LABORATORY TEST ABNORMAL 33 0.0011
652 PYREXIA 386 0.0011
653 JAUNDICE 30 0.0011
654 DISEASE RECURRENCE 53 0.0011
655 HEART RATE DECREASED 39 0.0011
656 HYPERSENSITIVITY 206 0.0011
657 PARAESTHESIA ORAL 16 0.0011
658 GASTROENTERITIS VIRAL 20 0.0011
659 GAIT INABILITY 37 0.0011
660 LUNG DISORDER 54 0.0011
661 TARDIVE DYSKINESIA 31 0.0011
662 BACTERAEMIA 13 0.0011
663 PERIPHERAL COLDNESS 15 0.0011
664 THERAPEUTIC RESPONSE UNEXPECTED 49 0.0011
665 SWELLING FACE 71 0.0011
666 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
667 MUSCULOSKELETAL STIFFNESS 95 0.0011
668 ANGINA PECTORIS 31 0.0011
669 DYSPEPSIA 106 0.0011
670 HEPATITIS C 13 0.0011
671 AGRANULOCYTOSIS 20 0.0011
672 EUPHORIC MOOD 11 0.0011
673 PLATELET COUNT INCREASED 14 0.0011
674 WOUND 30 0.0011
675 IRRITABLE BOWEL SYNDROME 23 0.0011
676 CARPAL TUNNEL SYNDROME 15 0.0011
677 NOCTURIA 13 0.0011
678 MUSCULOSKELETAL PAIN 56 0.0011
679 PANCREATITIS ACUTE 24 0.0011
680 JOINT STIFFNESS 28 0.0011
681 THIRST 19 0.0011
682 INTENTIONAL PRODUCT USE ISSUE 93 0.0011
683 MUSCLE SPASTICITY 13 0.0011
684 MALAISE 464 0.0011
685 URTICARIA 177 0.0011
686 PANCYTOPENIA 59 0.0011
687 MYOCARDIAL ISCHAEMIA 12 0.0011
688 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 75 0.0011
689 BLOOD URINE PRESENT 20 0.0011
690 DERMATITIS CONTACT 12 0.0011
691 GENERALISED OEDEMA 13 0.0010
692 OXYGEN SATURATION DECREASED 59 0.0010
693 FATIGUE 810 0.0010
694 PRODUCT TASTE ABNORMAL 14 0.0010
695 HYPOKINESIA 15 0.0010
696 WHITE BLOOD CELL COUNT DECREASED 112 0.0010
697 RETCHING 22 0.0010
698 DELUSION 16 0.0010
699 APATHY 15 0.0010
700 FEELING HOT 63 0.0010
701 HEPATIC ENZYME INCREASED 70 0.0010
702 ACUTE HEPATIC FAILURE 14 0.0010
703 BLOOD PRESSURE DECREASED 68 0.0010
704 HAEMOGLOBIN DECREASED 105 0.0010
705 COLD SWEAT 18 0.0010
706 RHINORRHOEA 66 0.0010
707 SYNCOPE 102 0.0010
708 PHARYNGITIS STREPTOCOCCAL 11 0.0010
709 EPISTAXIS 76 0.0010
710 SWELLING 95 0.0010
711 MUSCULOSKELETAL DISORDER 19 0.0010
712 PAIN IN EXTREMITY 294 0.0010
713 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
714 GASTROINTESTINAL DISORDER 89 0.0010
715 HAEMATURIA 34 0.0010
716 ARRHYTHMIA 47 0.0010
717 CHILLS 116 0.0010
718 URINARY RETENTION 33 0.0010
719 NIGHTMARE 34 0.0010
720 DECREASED APPETITE 228 0.0010
721 ADVERSE REACTION 13 0.0010
722 DYSTONIA 19 0.0010
723 METASTASES TO BONE 16 0.0010
724 DRUG INEFFECTIVE 1284 0.0010
725 CHOKING 19 0.0010
726 INJECTION SITE EXTRAVASATION 12 0.0010
727 CONJUNCTIVITIS 18 0.0010
728 EOSINOPHILIA 17 0.0010
729 ILEUS 12 0.0010
730 DEPRESSED MOOD 51 0.0010
731 MUSCLE SPASMS 177 0.0010
732 PRODUCT QUALITY ISSUE 131 0.0010
733 SCAB 11 0.0010
734 INTERNAL HAEMORRHAGE 11 0.0010
735 HYPOTENSION 193 0.0010
736 NIGHT SWEATS 31 0.0010
737 BRADYCARDIA 51 0.0010
738 PULMONARY OEDEMA 43 0.0010
739 BACK PAIN 223 0.0010
740 OEDEMA 52 0.0010
741 BLOOD PRESSURE FLUCTUATION 23 0.0010
742 SYSTEMIC LUPUS ERYTHEMATOSUS 34 0.0010
743 GASTROINTESTINAL HAEMORRHAGE 80 0.0010
744 PLATELET COUNT DECREASED 102 0.0010
745 NASAL CONGESTION 56 0.0010
746 UPPER RESPIRATORY TRACT INFECTION 44 0.0010
747 METASTASES TO LUNG 11 0.0010
748 PERICARDIAL EFFUSION 22 0.0010
749 PAIN 583 0.0009
750 PALPITATIONS 111 0.0009
751 HYPERKALAEMIA 33 0.0009
752 ABSCESS 15 0.0009
753 HYPERHIDROSIS 121 0.0009
754 SEPSIS 104 0.0009
755 OROPHARYNGEAL PAIN 86 0.0009
756 DYSGEUSIA 69 0.0009
757 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
758 OVERDOSE 199 0.0009
759 DRUG DOSE OMISSION 152 0.0009
760 ORTHOSTATIC HYPOTENSION 16 0.0009
761 ARTHROPATHY 51 0.0009
762 ANAEMIA 175 0.0009
763 PULMONARY HYPERTENSION 19 0.0009
764 CHRONIC KIDNEY DISEASE 69 0.0009
765 BURSITIS 11 0.0009
766 HEPATIC CIRRHOSIS 17 0.0009
767 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
768 EYE PAIN 51 0.0009
769 LUNG INFECTION 14 0.0009
770 TRANSAMINASES INCREASED 20 0.0009
771 FLATULENCE 51 0.0009
772 NAUSEA 710 0.0009
773 BLOOD GLUCOSE DECREASED 43 0.0009
774 THROMBOCYTOPENIA 100 0.0009
775 SNEEZING 20 0.0009
776 GOUT 16 0.0009
777 THERAPY NON-RESPONDER 40 0.0009
778 INCREASED APPETITE 17 0.0009
779 BONE PAIN 52 0.0009
780 CARDIO-RESPIRATORY ARREST 37 0.0009
781 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
782 SKIN CANCER 19 0.0009
783 IMPAIRED GASTRIC EMPTYING 12 0.0009
784 RENAL DISORDER 41 0.0009
785 CARDIOMYOPATHY 13 0.0009
786 LIVER DISORDER 39 0.0009
787 INFLUENZA 98 0.0009
788 PULMONARY MASS 13 0.0009
789 NEPHROLITHIASIS 40 0.0009
790 PLEURAL EFFUSION 53 0.0009
791 THROAT IRRITATION 39 0.0009
792 RESPIRATORY DISORDER 26 0.0009
793 HYPOAESTHESIA ORAL 13 0.0009
794 HAEMORRHAGE 90 0.0009
795 DISABILITY 17 0.0009
796 EMOTIONAL DISTRESS 104 0.0009
797 WITHDRAWAL SYNDROME 36 0.0009
798 MIDDLE INSOMNIA 16 0.0009
799 DRY MOUTH 69 0.0008
800 PRURITUS 326 0.0008
801 CARDIAC ARREST 70 0.0008
802 RESTLESSNESS 31 0.0008
803 HYPOGLYCAEMIA 41 0.0008
804 PRODUCT PHYSICAL ISSUE 17 0.0008
805 LYMPHOMA 13 0.0008
806 GALLBLADDER DISORDER 15 0.0008
807 IMMUNE SYSTEM DISORDER 11 0.0008
808 NEUTROPHIL COUNT DECREASED 34 0.0008
809 ABDOMINAL PAIN UPPER 171 0.0008
810 DIVERTICULITIS 23 0.0008
811 PNEUMOTHORAX 13 0.0008
812 NASOPHARYNGITIS 151 0.0008
813 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
814 SINUS CONGESTION 11 0.0008
815 HAEMATOMA 21 0.0008
816 SUICIDE ATTEMPT 49 0.0008
817 SURGERY 47 0.0008
818 ATRIAL FIBRILLATION 78 0.0008
819 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
820 ABORTION SPONTANEOUS 32 0.0008
821 MULTIPLE SCLEROSIS 38 0.0008
822 INFECTION 115 0.0008
823 LYMPHOCYTE COUNT DECREASED 14 0.0008
824 STOMATITIS 48 0.0008
825 PROTEINURIA 15 0.0008
826 FEEDING DISORDER 16 0.0008
827 COUGH 221 0.0008
828 CARDIOVASCULAR DISORDER 20 0.0008
829 ABDOMINAL PAIN 183 0.0008
830 HIP ARTHROPLASTY 12 0.0008
831 SKIN EXFOLIATION 66 0.0008
832 MYALGIA 133 0.0008
833 WHEEZING 46 0.0008
834 DYSPNOEA 439 0.0008
835 MUSCULOSKELETAL CHEST PAIN 12 0.0008
836 DIALYSIS 11 0.0008
837 LIVER INJURY 19 0.0008
838 MALIGNANT NEOPLASM PROGRESSION 79 0.0008
839 SINUSITIS 79 0.0008
840 PERIPHERAL SWELLING 118 0.0008
841 HEPATOTOXICITY 17 0.0008
842 AGEUSIA 19 0.0008
843 IMPAIRED HEALING 25 0.0008
844 FLUID OVERLOAD 11 0.0008
845 RESPIRATORY TRACT CONGESTION 12 0.0008
846 GASTROENTERITIS 11 0.0008
847 HAEMOPTYSIS 21 0.0008
848 EYE SWELLING 28 0.0008
849 GENERAL PHYSICAL HEALTH DETERIORATION 87 0.0008
850 BLOOD CREATININE INCREASED 49 0.0007
851 FUNGAL INFECTION 25 0.0007
852 ADVERSE DRUG REACTION 67 0.0007
853 DRUG EFFECT INCOMPLETE 27 0.0007
854 HAEMATOCHEZIA 41 0.0007
855 SKIN HAEMORRHAGE 11 0.0007
856 COLITIS 28 0.0007
857 PRODUCT DOSE OMISSION 48 0.0007
858 HERPES ZOSTER 42 0.0007
859 FLUID RETENTION 37 0.0007
860 VENTRICULAR TACHYCARDIA 12 0.0007
861 RHABDOMYOLYSIS 30 0.0007
862 ASTHMA 81 0.0007
863 RENAL IMPAIRMENT 60 0.0007
864 CHEST DISCOMFORT 73 0.0007
865 BLOOD GLUCOSE INCREASED 134 0.0007
866 TACHYCARDIA 63 0.0007
867 DIABETIC KETOACIDOSIS 17 0.0007
868 BASAL CELL CARCINOMA 11 0.0007
869 BACTERIAL INFECTION 13 0.0007
870 DRUG WITHDRAWAL SYNDROME 61 0.0007
871 ABDOMINAL DISCOMFORT 116 0.0007
872 SCIATICA 11 0.0007
873 NEOPLASM MALIGNANT 46 0.0007
874 INTENTIONAL OVERDOSE 44 0.0007
875 ACCIDENTAL OVERDOSE 25 0.0007
876 RASH PAPULAR 15 0.0007
877 INTENTIONAL DOSE OMISSION 19 0.0007
878 ADVERSE EVENT 61 0.0007
879 EXPIRED PRODUCT ADMINISTERED 22 0.0007
880 PELVIC PAIN 12 0.0007
881 PRODUCT AVAILABILITY ISSUE 15 0.0007
882 PRESYNCOPE 16 0.0007
883 MULTIPLE SCLEROSIS RELAPSE 45 0.0007
884 RESPIRATORY TRACT INFECTION 17 0.0007
885 DIARRHOEA 420 0.0007
886 GYNAECOMASTIA 20 0.0006
887 FLUSHING 65 0.0006
888 MUSCULOSKELETAL DISCOMFORT 11 0.0006
889 ARTHRALGIA 265 0.0006
890 ERYTHEMA 131 0.0006
891 INTESTINAL OBSTRUCTION 24 0.0006
892 MELAENA 14 0.0006
893 HYPOCALCAEMIA 12 0.0006
894 BLOOD BILIRUBIN INCREASED 17 0.0006
895 METASTASES TO LIVER 11 0.0006
896 INFLUENZA LIKE ILLNESS 51 0.0006
897 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
898 ACUTE MYOCARDIAL INFARCTION 18 0.0006
899 THERAPEUTIC RESPONSE DECREASED 37 0.0006
900 PRODUCTIVE COUGH 29 0.0006
901 EXTRAPYRAMIDAL DISORDER 15 0.0006
902 BLOOD PRESSURE ABNORMAL 12 0.0006
903 ABDOMINAL DISTENSION 63 0.0006
904 NEUTROPENIA 81 0.0006
905 METABOLIC ACIDOSIS 19 0.0006
906 FREQUENT BOWEL MOVEMENTS 16 0.0006
907 DYSPNOEA EXERTIONAL 22 0.0006
908 HOT FLUSH 44 0.0006
909 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
910 ANAPHYLACTIC REACTION 32 0.0006
911 GASTRIC ULCER 11 0.0006
912 ALOPECIA 113 0.0006
913 MUCOSAL INFLAMMATION 15 0.0006
914 DERMATITIS 12 0.0006
915 VIRAL INFECTION 19 0.0006
916 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
917 OSTEONECROSIS OF JAW 14 0.0006
918 ANGIOEDEMA 25 0.0006
919 PREMATURE BABY 17 0.0006
920 JOINT SWELLING 67 0.0006
921 THROAT TIGHTNESS 15 0.0006
922 OSTEONECROSIS 18 0.0005
923 INTENTIONAL SELF-INJURY 11 0.0005
924 INCORRECT DOSE ADMINISTERED 123 0.0005
925 APPLICATION SITE ERYTHEMA 14 0.0005
926 PRODUCT USE ISSUE 100 0.0005
927 OCULAR HYPERAEMIA 25 0.0005
928 RHEUMATOID ARTHRITIS 59 0.0005
929 OFF LABEL USE 452 0.0005
930 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
931 PNEUMONITIS 14 0.0005
932 PRODUCT COMPLAINT 13 0.0005
933 ACUTE KIDNEY INJURY 78 0.0005
934 HEPATIC FUNCTION ABNORMAL 19 0.0005
935 HOSPITALISATION 78 0.0005
936 VAGINAL HAEMORRHAGE 22 0.0005
937 ILLNESS 52 0.0005
938 INFUSION RELATED REACTION 33 0.0005
939 INJECTION SITE REACTION 34 0.0005
940 DISCOMFORT 30 0.0005
941 DEATH 413 0.0005
942 ABDOMINAL PAIN LOWER 12 0.0005
943 COMPLETED SUICIDE 39 0.0005
944 INFLAMMATION 24 0.0005
945 DRY SKIN 62 0.0005
946 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 33 0.0005
947 LACRIMATION INCREASED 14 0.0005
948 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
949 CARDIAC FAILURE 37 0.0005
950 EYE IRRITATION 26 0.0005
951 MENSTRUATION IRREGULAR 12 0.0004
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
953 DRUG RESISTANCE 11 0.0004
954 MATERNAL EXPOSURE DURING PREGNANCY 38 0.0004
955 PAIN OF SKIN 11 0.0004
956 THERAPEUTIC PRODUCT EFFECT DECREASED 18 0.0004
957 DRY EYE 20 0.0004
958 DRUG DEPENDENCE 62 0.0004
959 INJECTION SITE MASS 14 0.0004
960 ASCITES 11 0.0004
961 C-REACTIVE PROTEIN INCREASED 13 0.0004
962 THERAPY CESSATION 18 0.0004
963 INJECTION SITE HAEMORRHAGE 28 0.0004
964 FEBRILE NEUTROPENIA 23 0.0003
965 PRODUCT DOSE OMISSION ISSUE 99 0.0003
966 SKIN BURNING SENSATION 24 0.0003
967 PRODUCT USE IN UNAPPROVED INDICATION 83 0.0003
968 PLASMA CELL MYELOMA 13 0.0003
969 EYE PRURITUS 11 0.0003
970 BREAST CANCER 30 0.0003
971 EXTRA DOSE ADMINISTERED 13 0.0003
972 UNDERDOSE 23 0.0003
973 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
974 INJECTION SITE BRUISING 23 0.0003
975 SKIN IRRITATION 13 0.0003
976 COVID-19 49 0.0003
977 ACNE 21 0.0003
978 ECZEMA 14 0.0003
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 48 0.0003
980 INJECTION SITE ERYTHEMA 33 0.0003
981 INJECTION SITE PAIN 80 0.0003
982 DEVICE MALFUNCTION 18 0.0003
983 PROSTATE CANCER 20 0.0002
984 COLITIS ULCERATIVE 11 0.0002
985 THERAPY INTERRUPTED 17 0.0002
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 48 0.0002
987 PSORIASIS 30 0.0002
988 NO ADVERSE EVENT 35 0.0002
989 INJECTION SITE SWELLING 14 0.0002
990 TREATMENT FAILURE 15 0.0002
991 INJECTION SITE PRURITUS 12 0.0002
992 DEVICE ISSUE 15 0.0002
993 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001